Navigation Links
Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain

Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, New Products & Services Click to view news release full screen  

Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain


BASEL, Switzerland, Nov. 10 /PRNewswire/ - Neuro-Biotech Corporation (PINKSHEET: MRES) (OTCQB: MRES)

Neuro-Biotech Corp. is currently actively working towards the commercialization of natural products called "Neuroceuticals®", that are specially designed to restore the nervous system equilibrium and improve the state of health as well as the quality of life of people affected by stress-related disorders.

Our "Neuroceuticals®" respect international established quality standards (USP, EP and JP) in regards with purity, strength, and consistency of the products for human consumption.

According with our licences, we have a portfolio of four (4) innovative and selective products.

  • Neuro-Relax®
    A protein based supplement that favours the sleep's quality, decreases the anxiety and nervous pressure, improves general anxiety, anxious disorders, physical, emotional and mental stress and has a tranquilizing and soothing effect
  • Neuro-Learn®
    An adaptogene that helps stimulating the noradregenic and cholinergic systems resulting in improvement with memory, depression, concentration, attention and vigilance in particular with children suffering from attention deficit disorder which often need treatment with methylphenidate, among others marketed under the name of Ritalin®.
  • Neuro-Stim®
    An adoptogene which effect results in an increase in energy in order to reduce the effects of depression, hypoglycaemia, stress, obesity and type II diabetes as well as food behaviour's disorders such as bulimia.
  • Neuro-Lean®
    A product specially conceived to help with weight-loss management, optimizing the energetic spending as well as maintaining body weight.
  • Those four (4) products will be sold and distributed by many means; directly from us under our own label as well as through "Private labels" such as pharmacies, megastore and natural products brands. Since we are actively in a negotiation process, it will be the distributor's mandate, in terms of their respective part of the market, to target the clientele they believe should be reached.

    For more detailed information on the scientific data and the Neuroceuticals®, we invite you to consult our website at under the products section.

    Neuro-Biotech is currently negotiating with 2 separates groups on the East coast and West coast for them to distribute the Neuroceuticals®. Management also decided that in order to maximize the market penetration and based on the product composition, it was it the Company's best interest to categorize the Neuroceuticals® as Natural Products and Food Supplements.

    For more information, do not hesitate to contact us by using the contact form on our corporate website at Your request will be transferred to the appropriate persons and we will get back to you as soon as possible.

    SOURCE Neuro-Biotech Corp.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Mr Claude Poulin nominated as President and CEO of Neuro-Biotech Corp.
    2. Neuro-Biotechs Solution for a Doctor near You: Early Detection for Alzheimers and Chronic Fatigue Syndrome!
    4. NEURO-BIOTECH CORPORATION: Updates and latest developments
    5. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
    6. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
    7. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
    8. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
    9. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
    10. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
    11. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
    Post Your Comments:
    (Date:11/27/2015)... ... November 27, 2015 , ... Pittcon is pleased ... technical presentations offered in symposia, oral sessions, workshops, awards, and posters. The ... range of applications such as, but not limited to, biotechnology, biomedical, drug discovery, ...
    (Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
    (Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
    (Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) ... research organisation (CRO) market. The trend of outsourcing ... lower margins but higher volume share for the ... and scale, however, margins in the CRO industry ... (CRO) Market ( ), finds that ...
    Breaking Biology Technology:
    (Date:11/12/2015)... Nov. 12, 2015  Arxspan has entered into ... and Harvard for use of its ArxLab cloud-based ... tools. The partnership will support the institute,s efforts ... chemical research information internally and with external collaborators. ... for managing the Institute,s electronic laboratory notebook, compound ...
    (Date:11/11/2015)...   MedNet Solutions , an innovative SaaS-based eClinical technology ... pleased to announce that it will be a Sponsor of ... to be held November 17-19 in Hamburg ... of iMedNet , MedNet,s easy-to-use, proven and ... has been able to deliver time and cost savings of ...
    (Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
    Breaking Biology News(10 mins):